← Back to Search

Integrated vs. Coordinated Pain Management for Back Pain (AIM-BACK Trial)

N/A
Waitlist Available
Led By Steven Z George, PT, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >= 18
Be older than 18 years old
Must not have
Receiving or referred for hospice/ palliative care (defined by encounter codes and CPRS consults)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, three, six, and twelve months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether an Integrated Care Pathway or a Coordinated Care Pathway is more effective in reducing pain and improving function for people with low back pain.

Who is the study for?
This trial is for veterans aged 18 or older seeking conservative management for low back pain at participating VA clinics. They must not be in hospice/palliative care and need to have a documented phone number. Clinics should have distinct staff and locations from other enrolled clinics.
What is being tested?
The trial tests two quality improvement pathways for managing low back pain: an Integrated Care Pathway (ICP) with sequenced treatments, and a Coordinated Care Management Pathway (CCP). It aims to see which pathway better reduces pain interference with activities and improves physical function.
What are the potential side effects?
Since the interventions include non-pharmacological treatments like behavioral therapy, physical treatment, self-management counseling, and referrals to pain resources, side effects are minimal but may include discomfort due to increased activity or psychological distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving or have been referred for end-of-life care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, three months post baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, three months post baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Pain Interference Measure
Change in Physical Function Measure
Secondary study objectives
Change in Opioid Use--Chronic User
Change in Opioid Use--Morphine Dose
Change in Patient Reported Outcomes--PROMIS Pain Interference
+3 more
Other study objectives
Alcohol Use Disorder
Change in Patient Reported Outcomes--Catastrophizing
Change in Patient Reported Outcomes--Depressed Mood
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Coordinated Care Management PathwayActive Control3 Interventions
The care management pathway involves a referral of patients from a physician to a pain navigator on site at the local VA who is knowledgeable in current recommended treatment guidelines for low back pain.
Group II: Integrated Care PathwayActive Control3 Interventions
The integrated care pathway provides both on-site physical therapy services and centrally-delivered services via telephone or video from study providers at the Durham VA.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillOTHER
1,555 Previous Clinical Trials
4,296,618 Total Patients Enrolled
Durham VA Medical CenterFED
39 Previous Clinical Trials
7,529 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
854 Previous Clinical Trials
669,925 Total Patients Enrolled

Media Library

Nonpharmacological guideline adherent treatment protocol Clinical Trial Eligibility Overview. Trial Name: NCT04411420 — N/A
Lower Back Pain Research Study Groups: Coordinated Care Management Pathway, Integrated Care Pathway
Lower Back Pain Clinical Trial 2023: Nonpharmacological guideline adherent treatment protocol Highlights & Side Effects. Trial Name: NCT04411420 — N/A
Nonpharmacological guideline adherent treatment protocol 2023 Treatment Timeline for Medical Study. Trial Name: NCT04411420 — N/A
~389 spots leftby Nov 2025